Acorda Therapeutics is a biopharmaceutical company based in Ardsley, New York, specializing in the research, development, and commercialization of drugs for the treatment of neurological disorders. The company focuses on treating multiple sclerosis (MS) and other neurological disorders such as Parkinson's disease.
Feed
There are no posts to show right now.
We use cookies to improve your experience on our site.